SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells

PLoS Pathog. 2021 Jan 21;17(1):e1009233. doi: 10.1371/journal.ppat.1009233. eCollection 2021 Jan.

Abstract

The spike (S) protein of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) binds to a host cell receptor which facilitates viral entry. A polybasic motif detected at the cleavage site of the S protein has been shown to broaden the cell tropism and transmissibility of the virus. Here we examine the properties of SARS-CoV-2 variants with mutations at the S protein cleavage site that undergo inefficient proteolytic cleavage. Virus variants with S gene mutations generated smaller plaques and exhibited a more limited range of cell tropism compared to the wild-type strain. These alterations were shown to result from their inability to utilize the entry pathway involving direct fusion mediated by the host type II transmembrane serine protease, TMPRSS2. Notably, viruses with S gene mutations emerged rapidly and became the dominant SARS-CoV-2 variants in TMPRSS2-deficient cells including Vero cells. Our study demonstrated that the S protein polybasic cleavage motif is a critical factor underlying SARS-CoV-2 entry and cell tropism. As such, researchers should be alert to the possibility of de novo S gene mutations emerging in tissue-culture propagated virus strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Caco-2 Cells
  • Cell Line
  • Chlorocebus aethiops
  • HEK293 Cells
  • Humans
  • Mutation
  • SARS-CoV-2 / classification
  • SARS-CoV-2 / genetics*
  • SARS-CoV-2 / growth & development
  • SARS-CoV-2 / physiology
  • Sequence Alignment
  • Serial Passage
  • Serine Endopeptidases / deficiency*
  • Spike Glycoprotein, Coronavirus / genetics*
  • Vero Cells
  • Viral Tropism

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • Serine Endopeptidases
  • TMPRSS2 protein, human

Grants and funding

This work was supported in part by the Japan Agency for Medical Research and Development (AMED) [20wm0225003(HS), 20wm0125008(HS)] and Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16H06429(HS), 16H06431(HS), 16K21723(HS)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.